These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 24989915)
1. [Clinicopathological characteristics and imaging features of pulmonary adenocarcinoma with micropapillary pattern]. Ren J; Zhou J; Ding W; Zhong B; Zhou J Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):282-6. PubMed ID: 24989915 [TBL] [Abstract][Full Text] [Related]
2. Risk factors for lymph node metastasis and surgical methods in patients with early-stage peripheral lung adenocarcinoma presenting as ground glass opacity. Wang Y; Jing L; Wang G J Cardiothorac Surg; 2020 Aug; 15(1):121. PubMed ID: 32782020 [TBL] [Abstract][Full Text] [Related]
3. Minor components of micropapillary and solid subtypes in lung invasive adenocarcinoma (≤ 3 cm): PET/CT findings and correlations with lymph node metastasis. Chang C; Sun X; Zhao W; Wang R; Qian X; Lei B; Wang L; Liu L; Ruan M; Xie W; Shen J Radiol Med; 2020 Mar; 125(3):257-264. PubMed ID: 31823295 [TBL] [Abstract][Full Text] [Related]
4. Pulmonary adenocarcinoma with micropapillary component: an immunohistochemical study. Case report. Kuroda N; Hamauzu T; Toi M; Yamaoka K; Miyazaki E; Hiroi M; Nakata H; Taguchi H; Enzan H APMIS; 2005; 113(7-8):550-4. PubMed ID: 16086826 [TBL] [Abstract][Full Text] [Related]
5. [Correlation analysis between imaging features and lymph node metastasis in T1a lung adenocarcinoma]. Ye B; Feng J; Pan XF; Yang Y; Geng JF; Cao KJ; Zhao H; Hu DZ Zhonghua Wai Ke Za Zhi; 2013 Oct; 51(10):904-7. PubMed ID: 24433769 [TBL] [Abstract][Full Text] [Related]
6. [Pulmonary adenocarcinoma with micropapillary pattern: a clinicopathologic and immunohistochemical study]. Zhang J; Liang ZY; Luo YF; Wan JW; Cao JL; Liu TH Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):651-6. PubMed ID: 20078967 [TBL] [Abstract][Full Text] [Related]
7. Does ground glass opacity-dominant feature have a prognostic significance even in clinical T2aN0M0 lung adenocarcinoma? Nakamura S; Fukui T; Kawaguchi K; Fukumoto K; Hirakawa A; Yokoi K Lung Cancer; 2015 Jul; 89(1):38-42. PubMed ID: 25963638 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathological Characteristics of Lung Adenocarcinoma with Unexpected Lymph Node Metastasis. Haruki T; Wakahara M; Matsuoka Y; Miwa K; Araki K; Taniguchi Y; Nakamura H Ann Thorac Cardiovasc Surg; 2017 Aug; 23(4):181-187. PubMed ID: 28539542 [TBL] [Abstract][Full Text] [Related]
9. Factors associated with lymph node metastasis upstage after resection for patients with micropapillary lung adenocarcinoma. Matsushima K; Sonoda D; Mitsui A; Tamagawa S; Hayashi S; Naito M; Matsui Y; Shiomi K; Satoh Y Thorac Cancer; 2022 Jan; 13(1):48-53. PubMed ID: 34866323 [TBL] [Abstract][Full Text] [Related]
10. Association between high-resolution computed tomography findings and the IASLC/ATS/ERS classification of small lung adenocarcinomas in Japanese patients. Kudo Y; Matsubayashi J; Saji H; Akata S; Shimada Y; Kato Y; Kakihana M; Kajiwara N; Ohira T; Nagao T; Ikeda N Lung Cancer; 2015 Oct; 90(1):47-54. PubMed ID: 26259875 [TBL] [Abstract][Full Text] [Related]
11. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery]. Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559 [TBL] [Abstract][Full Text] [Related]
12. Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: A predictor of lymph node metastasis. Matsuguma H; Yokoi K; Anraku M; Kondo T; Kamiyama Y; Mori K; Tominaga K; Tsuura Y; Honjo S J Thorac Cardiovasc Surg; 2002 Aug; 124(2):278-84. PubMed ID: 12167787 [TBL] [Abstract][Full Text] [Related]
13. Predictive factors for lymph node metastasis in clinical stage IA lung adenocarcinoma. Ye B; Cheng M; Li W; Ge XX; Geng JF; Feng J; Yang Y; Hu DZ Ann Thorac Surg; 2014 Jul; 98(1):217-23. PubMed ID: 24841547 [TBL] [Abstract][Full Text] [Related]
14. Diagnosis of lymph node micrometastasis at the pN₀ stage of lung adenocarcinoma using a combination of markers. Liu H; Ye YK; Li GM; Zhou Y; Han KB; Xu G; Wang D Genet Mol Res; 2014 Jul; 13(3):5594-600. PubMed ID: 25117316 [TBL] [Abstract][Full Text] [Related]
15. Lung adenocarcinoma with a micropapillary pattern: a clinicopathological study of 25 cases. Kuroda N; Hamaguchi N; Takeuchi E; Ohara M; Hirouchi T; Mizuno K APMIS; 2006 May; 114(5):381-5. PubMed ID: 16725015 [TBL] [Abstract][Full Text] [Related]
16. [Correlation of caveolin-1 expression with clinicopathologic features and prognosis in patients with lung adenocarcinoma]. Wang Y; Liu B; Xu Y; Zhang J; Xia Q; Yu B; Zhang R; Shi S; Lu Z; Zhou X Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):251-5. PubMed ID: 24915816 [TBL] [Abstract][Full Text] [Related]
17. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection. Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1365-71. PubMed ID: 22883546 [TBL] [Abstract][Full Text] [Related]
18. Comparison between solid component size on thin-section CT and pathologic lymph node metastasis and local invasion in T1 lung adenocarcinoma. Hayashi H; Ashizawa K; Ogihara Y; Nishida A; Matsumoto K; Yamasaki N; Nagayasu T; Fukuda M; Honda S; Uetani M Jpn J Radiol; 2017 Mar; 35(3):109-115. PubMed ID: 28110435 [TBL] [Abstract][Full Text] [Related]
19. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification predicts occult lymph node metastasis in clinically mediastinal node-negative lung adenocarcinoma. Yeh YC; Kadota K; Nitadori J; Sima CS; Rizk NP; Jones DR; Travis WD; Adusumilli PS Eur J Cardiothorac Surg; 2016 Jan; 49(1):e9-e15. PubMed ID: 26377636 [TBL] [Abstract][Full Text] [Related]
20. Computed tomography and clinical features associated with epidermal growth factor receptor mutation status in stage I/II lung adenocarcinoma. Zou J; Lv T; Zhu S; Lu Z; Shen Q; Xia L; Wu J; Song Y; Liu H Thorac Cancer; 2017 May; 8(3):260-270. PubMed ID: 28383802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]